The role of F-18 positron emission tomography/computed tomography in evaluation of extranodal lymphoma
ConclusionPET/CT is superior over CT alone in detecting extranodal extension especially among splenic, bone and bone marrow lesions.
We present a case report of an adult woman with AKL-positive ALCL, diagnosed by endobronchial ultrasound-guided transbronchial needle aspirate (EBUS-TBNA).A 59-year-old women with no history of breast implants, was admitted for a four-month low back pain. Initially, the patient was treated for a spondyloarthropathy, but due to persistence of the symptoms, a lumbosacral MRI was performed, showing changes in morphology and signal intensity in the vertebral body of L3, along with edema and a paravertebral collection that affected the left psoas muscle, suggesting granulomatous spondylodiscitis. Chest CT-scan showed mild left ...
ConclusionIn this cohort of ESHL patients who responded completely to frontline therapy, the relapse rate was low. Routine imaging surveillance lacks clinical benefit in this patient population.
ABVD (doxorubicin, bleomycin, vinblastine, dacarbazine) is standard upfront chemotherapy for adults diagnosed with Hodgkin lymphoma (HL), but positron emission tomography (PET)-based response data following ABVD is lacking for pediatrics. Among children who received ABVD for HL, we document interim and end of therapy PET-computed tomography (CT) response by Deauville criteria, and survival outcomes following a response-based reduction in involved field radiotherapy (IFRT). Children 18 years of age or below with HL treated with ABVD between 2006 and 2015 who had interim PET/CT scans after 2 cycles of chemotherapy were inclu...
ConclusionPCNSL with atypical radiological features represented one-fourth of our histologically diagnosed lymphoma cases; low ADC values in atypical lesions should prompt clinicians to consider early biopsy for definitive diagnosis.
Conclusion 18F-FDG PET/CT seemed to be an excellent diagnostic test in assessment of BMI at initial assessment and staging of Hodgkin lymphoma and DLBCL patients.
We examined the imaging surveillance strategy of early stage HL patients who responded completely to frontline therapy at a single institution. The rate of relapse was low suggesting no benefit for follow up positron emission tomography- computed tomography (PET-CT) and CT imaging studies in this patient population.
We present a case of T-cell/histiocyte-rich B-cell lymphoma who had acute renal failure at initial presentation with bilateral lymphomatous infiltration depicted on FDG PET/CT scan. Four months after the treatment, a repeat FDG PET/CT scan revealed complete resolution of the renal lesions, indicative of the complete remission for kidneys.
Conclusions: Endoscopic treatment with a rehabilitation program may be a valuable strategy for the management of lung abscess that is refractory to standard antibiotic therapy. Further and larger studiesshould be done to confirm our results.
ConclusionsDespite several limitations affect this analysis, especially related to the heterogeneity of the studies included, MCL is an 18F-FDG-avid lymphoma in most of the cases, with the exception of BM and GI disease. Moreover, 18F-FDG PET/CT seems to be useful in evaluating treatment response and prognosis.
The patient presents with stage IV diffuse large B-cell lymphoma (DLBCL) with a right ventricular mass and a malignant pericardial effusion with pericardial implants based on positron emission tomography-computed tomography (PET-CT).1 He does not appear to have bulky disease (>7.5 cm). His International Prognostic Index score puts him in a high-risk cohort. The patient is in remission after 6 cycles of R-CHOP (rituximab, cyclophosphamide, doxorubicin, vincristine, and prednisone). Consolidation radiation therapy (RT) is not routinely used in advanced DLBCL but may play a ro le in select patients.